Which treatment can assist with placental resorption if future fertility is desired?

Methotrexate is an effective treatment for placental resorption, particularly in conditions such as an ectopic pregnancy or during certain abortion procedures. It is a chemotherapy agent that interferes with DNA synthesis, which can help to decrease the trophoblastic tissue and promote the resorption of the placenta. This is particularly important for patients desiring future fertility, as methotrexate allows the uterus to remain intact, preserving the potential for future pregnancies.

In contrast, hysterectomy involves the surgical removal of the uterus, which would eliminate any chance for future fertility. Myomectomy is a surgical procedure to remove fibroids from the uterus and does not directly address placental resorption. Induced labor is also not appropriate for treating placental resorption because it is typically used to initiate labor and does not facilitate the resorption of placental tissue. Therefore, methotrexate is the most suitable option for individuals wishing to maintain their fertility following complications related to placental conditions.